Back to results
CompletedPhase 2

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

NCT03162874

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Universitätsklinik für Innere Medizin VI Innsbruck, Neurologisches Studienzentrum

Innsbruck, Austria

+44 additional locations

View on ClinicalTrials.gov